Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $69.54 USD
Change Today -0.47 / -0.67%
Volume 734.8K
CRL On Other Exchanges
Symbol
Exchange
Berlin
As of 8:04 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for charles river laboratories (CRL)

Year over year, Charles River Laboratories International, Inc. has been able to grow revenues from $1.2B USD to $1.3B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 64.31% to 62.96%. This was a driver that led to a bottom line growth from $102.8M USD to $126.7M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 29
2012
Dec 28
2013
Restated
Dec 27
2014
4 Year
Trend
Revenues1,142.61,129.51,165.51,297.7
TOTAL REVENUES1,142.61,129.51,165.51,297.7
Cost of Goods Sold739.4732.7749.5817.0
GROSS PROFIT403.3396.8416.0480.6
Selling General & Admin Expenses, Total206.2203.1222.2258.2
Depreciation & Amortization, Total21.818.117.826.0
OTHER OPERATING EXPENSES, TOTAL228.0221.2240.0284.1
OPERATING INCOME175.3175.7176.0196.5
Interest Expense-42.6-33.3-21.0-11.9
Interest and Investment Income1.40.60.71.2
NET INTEREST EXPENSE-41.2-32.8-20.2-10.8
Income (Loss) on Equity Investments0.9-0.65.99.3
Currency Exchange Gains (Loss)6.2------
Other Non-Operating Income (Expenses)-7.5-2.61.3-0.7
EBT, EXCLUDING UNUSUAL ITEMS133.6139.6162.9194.3
Merger & Restructuring Charges-14.3-9.9-20.8-18.8
Other Unusual Items, Total13.3---3.82.1
Insurance Settlements7.7------
Other Unusual Items5.6----2.1
EBT, INCLUDING UNUSUAL ITEMS132.7129.7138.3177.6
Income Tax Expense17.127.632.947.7
Minority Interest in Earnings-0.4-0.6-1.3-1.5
Earnings from Continuing Operations115.5102.1105.4129.9
EARNINGS FROM DISCOUNTINUED OPERATIONS-5.5-4.3-1.3-1.7
NET INCOME109.697.3102.8126.7
NET INCOME TO COMMON INCLUDING EXTRA ITEMS109.697.3102.8126.7
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS115.1101.5104.1128.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRL:US $69.54 USD -0.47

CRL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bioanalytical Systems Inc $1.98 USD +0.01
Ergomed PLC 180.00 GBp +0.50
PAREXEL International Corp $64.68 USD +0.01
Quintiles Transnational Holdings Inc $72.80 USD -0.17
WuXi PharmaTech Cayman Inc $41.82 USD -0.17
View Industry Companies
 

Industry Analysis

CRL

Industry Average

Valuation CRL Industry Range
Price/Earnings 25.9x
Price/Sales 2.5x
Price/Book 5.0x
Price/Cash Flow 21.5x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHARLES RIVER LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.